Allergan Income Statement
View: Annual | Quarterly
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 3,938.9 | 3,063.3 | 2,319.2 |
| Cost of Goods Sold | 673.2 | 575.7 | 399.6 |
| Gross Profit | 3,265.7 | 2,487.6 | 1,919.6 |
| Gross Profit Margin | 82.9% | 81.2% | 82.8% |
| SG&A Expense | 2,327.6 | 2,329.3 | 1,260.0 |
| Depreciation & Amortization | 218.7 | 161.5 | 88.7 |
| Operating Income | 719.4 | (3.2) | 570.9 |
| Operating Margin | 18.3% | -- | 24.6% |
| Nonoperating Income | 39.7 | 43.9 | 40.7 |
| Nonoperating Expenses | 71.4 | 60.2 | 12.4 |
| Income Before Taxes | 687.7 | (19.5) | 599.2 |
| Income Taxes | 186.2 | 107.5 | 192.4 |
| Net Income After Taxes | 501.5 | (127.0) | 406.8 |
| Continuing Operations | 501.0 | (127.4) | 403.9 |
| Discontinued Operations | (1.7) | -- | -- |
| Total Operations | 499.3 | (127.4) | 403.9 |
| Total Net Income | 499.3 | (127.4) | 403.9 |
| Net Profit Margin | 12.7% | -- | 17.4% |
| Diluted EPS from Total Net Income ($) | 1.62 | (0.44) | 1.50 |
| Dividends per Share | 0.20 | 0.20 | 0.20 |




